Last $52.03 USD
Change Today 0.00 / 0.00%
Volume 0.0
CTRX On Other Exchanges
Symbol
Exchange
Toronto
NASDAQ GS
Berlin
As of 8:10 PM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

catamaran corp (CTRX) Key Developments

Catamaran Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 09:00 AM

Catamaran Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 09:00 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Mark A. Thierer, Chairman and Chief Executive Officer, Michael H. Shapiro, Chief Financial Officer and Senior Vice President.

Catamaran Corporation Presents at Bank of America Merrill Lynch 2014 Leveraged Finance Conference, Dec-03-2014 08:10 AM

Catamaran Corporation Presents at Bank of America Merrill Lynch 2014 Leveraged Finance Conference, Dec-03-2014 08:10 AM. Venue: Boca Raton Resort & Club, 501 East Camino Real, Boca Raton, Florida, United States. Speakers: Mike Shapiro, Chief Financial Officer.

Catamaran Corporation Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for the Full Year 2014

Catamaran Corporation announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenue of $5,541,713,000 against $3,614,148,000 a year ago. Operating income was $147,993,000 against $120,135,000 a year ago. Income before income taxes was $130,075,000 against $111,109,000 a year ago. Net income attributable to the company was $81,968,000 or $0.39 per diluted share against $72,938,000 or $0.35 per diluted share a year ago. Net cash provided by operating activities was $234,210,000 against $99,519,000 a year ago. Purchases of property and equipment were $13,336,000 against $21,137,000 a year ago. Non-GAAP net income attributable to the company was $120,608,000 or $0.58 per diluted share against $108,259,000 or $0.52 per diluted share a year ago. EBITDA was $205,704,000 against $167,551,000 a year ago. The company generated $427 million in cash flow through the third quarter 2014. For the nine months, the company reported revenue of $15,842,000,000 against $10,251,295,000 a year ago. Operating income was $399,893,000 against $317,655,000 a year ago. Income before income taxes was $355,011,000 against $286,683,000 a year ago. Net income attributable to the company was $216,845,000 or $1.05 per diluted share against $187,764,000 or $0.91 per diluted share a year ago. Net cash provided by operating activities was $427,094,000 against $335,853,000 a year ago. Purchases of property and equipment were $46,209,000 against $93,272,000 a year ago. Non-GAAP net income attributable to the company was $335,560,000 or $1.62 per diluted share against $296,227,000 or $1.43 per diluted share a year ago. EBITDA was $565,061,000 against $469,153,000 a year ago. For the full year 2014, the company expected revenue of $21.1 to $21.5 billion, EBITDA of $780 to $795 million, GAAP EPS (fully-diluted) of $1.45 to $1.50 and adjusted EPS (fully-diluted) of $2.20 to $2.25 (excluding all amortization of intangible assets, net of tax). The company expected full year effective tax rate of approximately 27%. The base EBITDA organic growth The company expects to deliver in 2014 of 12% to 14% is a reasonable expectation for organic growth in 2015.

Catamaran Corporation Presents at Credit Suisse Annual Healthcare Conference, Nov-12-2014 09:30 AM

Catamaran Corporation Presents at Credit Suisse Annual Healthcare Conference, Nov-12-2014 09:30 AM. Venue: The Biltmore, 2400 E Missouri Ave, Phoenix, AZ 85016, United States. Speakers: Michael H. Shapiro, Chief Financial Officer and Senior Vice President.

Catamaran Corporation to Report Q3, 2014 Results on Oct 30, 2014

Catamaran Corporation announced that they will report Q3, 2014 results at 6:00 AM, US Eastern Standard Time on Oct 30, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CTRX:US $52.03 USD 0.00

CTRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Anthem Inc $138.70 USD 0.00
BioScrip Inc $5.92 USD 0.00
Cigna Corp $109.41 USD 0.00
Express Scripts Holding Co $84.75 USD 0.00
Walgreens Boots Alliance Inc $75.84 USD 0.00
View Industry Companies
 

Industry Analysis

CTRX

Industry Average

Valuation CTRX Industry Range
Price/Earnings 37.1x
Price/Sales 0.5x
Price/Book 2.1x
Price/Cash Flow 19.1x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CATAMARAN CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.